CME Group (CME) Announces Quarterly Earnings Results

CME Group (NASDAQ:CME) posted its earnings results on Thursday. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.03, MarketWatch Earnings reports. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The firm had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million.

Shares of CME traded up $1.17 during trading hours on Friday, hitting $178.64. The stock had a trading volume of 1,740,913 shares, compared to its average volume of 1,576,868. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.08 and a quick ratio of 1.08. The stock has a market cap of $61.53 billion, a P/E ratio of 37.45, a P/E/G ratio of 3.45 and a beta of 0.64. CME Group has a fifty-two week low of $134.09 and a fifty-two week high of $183.79.

In other CME Group news, President Bryan T. Durkin sold 11,509 shares of the company’s stock in a transaction on Monday, August 6th. The shares were sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the completion of the transaction, the president now directly owns 64,862 shares in the company, valued at $10,508,292.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 1,823 shares of the company’s stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $175.00, for a total transaction of $319,025.00. Following the transaction, the insider now owns 30,176 shares of the company’s stock, valued at $5,280,800. The disclosure for this sale can be found here. Insiders have sold 29,188 shares of company stock valued at $4,973,607 over the last 90 days. 0.43% of the stock is currently owned by company insiders.



Several equities analysts recently issued reports on CME shares. BidaskClub cut shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 28th. Wells Fargo & Co boosted their target price on shares of CME Group from $170.00 to $175.00 and gave the company a “market perform” rating in a research note on Monday, July 9th. Compass Point started coverage on shares of CME Group in a research note on Monday, July 9th. They issued a “neutral” rating and a $170.00 target price for the company. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, August 22nd. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $190.00 target price on shares of CME Group in a research note on Wednesday, September 5th. Five analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. CME Group has a consensus rating of “Buy” and an average target price of $181.54.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Recommended Story: Asset Allocation

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply